 | • レポートコード：MRC2012A6905 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ペプチド・ヘパリンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ペプチド・ヘパリンの種類別市場規模（インスリン、テリパラチド、リラグルチド、リュープロリド、リュープロリド、エクセナチド、カルシトニン、エナキサパリンナトリウム、ヘパリンナトリウム）、用途別市場規模（糖尿病、感染症、がん、骨粗鬆症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Cipla Ltd.、VHB Life Sciences Limited、Troikaa Pharmaceuticals Ltd.、Emcure Pharmaceuticals Pvt. Ltd.、Samarth Life Sciences Pvt. Ltd.、Gland Pharma Limited、United Biotech (P) Limited、Bharat Biotech、Biological E Limited、Celon Laboratories Pvt. Ltd.、Biocon Limited、Sun Pharmaceutical Industries Ltd.、Wockhardt Ltd.、 ・地域別グローバル市場分析 2015年-2020年 ・ペプチド・ヘパリンの北米市場（アメリカ、カナダ、メキシコ） ・ペプチド・ヘパリンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ペプチド・ヘパリンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ペプチド・ヘパリンの南米市場（ブラジル、アルゼンチン） ・ペプチド・ヘパリンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：インスリン、テリパラチド、リラグルチド、リュープロリド、リュープロリド、エクセナチド、カルシトニン、エナキサパリンナトリウム、ヘパリンナトリウム ・用途別分析：糖尿病、感染症、がん、骨粗鬆症 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Peptides and Heparin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Peptides and Heparin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Peptides and Heparin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Peptides and Heparin market has been segmented into
Insulin
Teriparatide
Liraglutide
Leuprolide
Leuprolide
Exenatide
Calcitonin
Enaxaparin Sodium
Heparin Sodium
By Application, Peptides and Heparin has been segmented into:
Diabetes
Infectious Diseases
Cancer
Osteoporosis
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Peptides and Heparin market presented in the report. This section sheds light on the sales growth of different regional and country-level Peptides and Heparin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Peptides and Heparin market.
The report offers in-depth assessment of the growth and other aspects of the Peptides and Heparin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Peptides and Heparin Market Share Analysis
Peptides and Heparin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Peptides and Heparin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Peptides and Heparin sales, revenue and market share for each player covered in this report.
The major players covered in Peptides and Heparin are:
Cipla Ltd.
VHB Life Sciences Limited
Troikaa Pharmaceuticals Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Samarth Life Sciences Pvt. Ltd.
Gland Pharma Limited
United Biotech (P) Limited
Bharat Biotech
Biological E Limited
Celon Laboratories Pvt. Ltd.
Biocon Limited
Sun Pharmaceutical Industries Ltd.
Wockhardt Ltd.
Among other players domestic and global, Peptides and Heparin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peptides and Heparin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peptides and Heparin, with price, sales, revenue and global market share of Peptides and Heparin in 2018 and 2019.
Chapter 3, the Peptides and Heparin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peptides and Heparin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Peptides and Heparin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Peptides and Heparin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Peptides and Heparin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peptides and Heparin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Insulin
1.2.3 Teriparatide
1.2.4 Liraglutide
1.2.5 Leuprolide
1.2.6 Leuprolide
1.2.7 Exenatide
1.2.8 Calcitonin
1.2.9 Enaxaparin Sodium
1.2.10 Heparin Sodium
1.3 Market Analysis by Application
1.3.1 Overview: Global Peptides and Heparin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diabetes
1.3.3 Infectious Diseases
1.3.4 Cancer
1.3.5 Osteoporosis
1.4 Overview of Global Peptides and Heparin Market
1.4.1 Global Peptides and Heparin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cipla Ltd.
2.1.1 Cipla Ltd. Details
2.1.2 Cipla Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Cipla Ltd. SWOT Analysis
2.1.4 Cipla Ltd. Product and Services
2.1.5 Cipla Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 VHB Life Sciences Limited
2.2.1 VHB Life Sciences Limited Details
2.2.2 VHB Life Sciences Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 VHB Life Sciences Limited SWOT Analysis
2.2.4 VHB Life Sciences Limited Product and Services
2.2.5 VHB Life Sciences Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Troikaa Pharmaceuticals Ltd.
2.3.1 Troikaa Pharmaceuticals Ltd. Details
2.3.2 Troikaa Pharmaceuticals Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Troikaa Pharmaceuticals Ltd. SWOT Analysis
2.3.4 Troikaa Pharmaceuticals Ltd. Product and Services
2.3.5 Troikaa Pharmaceuticals Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Emcure Pharmaceuticals Pvt. Ltd.
2.4.1 Emcure Pharmaceuticals Pvt. Ltd. Details
2.4.2 Emcure Pharmaceuticals Pvt. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Emcure Pharmaceuticals Pvt. Ltd. SWOT Analysis
2.4.4 Emcure Pharmaceuticals Pvt. Ltd. Product and Services
2.4.5 Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Samarth Life Sciences Pvt. Ltd.
2.5.1 Samarth Life Sciences Pvt. Ltd. Details
2.5.2 Samarth Life Sciences Pvt. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Samarth Life Sciences Pvt. Ltd. SWOT Analysis
2.5.4 Samarth Life Sciences Pvt. Ltd. Product and Services
2.5.5 Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Gland Pharma Limited
2.6.1 Gland Pharma Limited Details
2.6.2 Gland Pharma Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Gland Pharma Limited SWOT Analysis
2.6.4 Gland Pharma Limited Product and Services
2.6.5 Gland Pharma Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 United Biotech (P) Limited
2.7.1 United Biotech (P) Limited Details
2.7.2 United Biotech (P) Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 United Biotech (P) Limited SWOT Analysis
2.7.4 United Biotech (P) Limited Product and Services
2.7.5 United Biotech (P) Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bharat Biotech
2.8.1 Bharat Biotech Details
2.8.2 Bharat Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bharat Biotech SWOT Analysis
2.8.4 Bharat Biotech Product and Services
2.8.5 Bharat Biotech Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biological E Limited
2.9.1 Biological E Limited Details
2.9.2 Biological E Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biological E Limited SWOT Analysis
2.9.4 Biological E Limited Product and Services
2.9.5 Biological E Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Celon Laboratories Pvt. Ltd.
2.10.1 Celon Laboratories Pvt. Ltd. Details
2.10.2 Celon Laboratories Pvt. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Celon Laboratories Pvt. Ltd. SWOT Analysis
2.10.4 Celon Laboratories Pvt. Ltd. Product and Services
2.10.5 Celon Laboratories Pvt. Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Biocon Limited
2.11.1 Biocon Limited Details
2.11.2 Biocon Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Biocon Limited SWOT Analysis
2.11.4 Biocon Limited Product and Services
2.11.5 Biocon Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sun Pharmaceutical Industries Ltd.
2.12.1 Sun Pharmaceutical Industries Ltd. Details
2.12.2 Sun Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sun Pharmaceutical Industries Ltd. SWOT Analysis
2.12.4 Sun Pharmaceutical Industries Ltd. Product and Services
2.12.5 Sun Pharmaceutical Industries Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Wockhardt Ltd.
2.13.1 Wockhardt Ltd. Details
2.13.2 Wockhardt Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Wockhardt Ltd. SWOT Analysis
2.13.4 Wockhardt Ltd. Product and Services
2.13.5 Wockhardt Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Peptides and Heparin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Peptides and Heparin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Peptides and Heparin Manufacturer Market Share in 2019
3.3.2 Top 6 Peptides and Heparin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Peptides and Heparin Sales, Revenue and Market Share by Regions
4.1.1 Global Peptides and Heparin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Peptides and Heparin Revenue and Market Share by Regions (2015-2020)
4.2 North America Peptides and Heparin Sales and Growth Rate (2015-2020)
4.3 Europe Peptides and Heparin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Peptides and Heparin Sales and Growth Rate (2015-2020)
4.5 South America Peptides and Heparin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Peptides and Heparin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Peptides and Heparin Sales, Revenue and Market Share by Country
5.1.1 North America Peptides and Heparin Sales and Market Share by Country (2015-2020)
5.1.2 North America Peptides and Heparin Revenue and Market Share by Country (2015-2020)
5.2 United States Peptides and Heparin Sales and Growth Rate (2015-2020)
5.3 Canada Peptides and Heparin Sales and Growth Rate (2015-2020)
5.4 Mexico Peptides and Heparin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Peptides and Heparin Sales, Revenue and Market Share by Country
6.1.1 Europe Peptides and Heparin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Peptides and Heparin Revenue and Market Share by Country (2015-2020)
6.2 Germany Peptides and Heparin Sales and Growth Rate (2015-2020)
6.3 UK Peptides and Heparin Sales and Growth Rate (2015-2020)
6.4 France Peptides and Heparin Sales and Growth Rate (2015-2020)
6.5 Russia Peptides and Heparin Sales and Growth Rate (2015-2020)
6.6 Italy Peptides and Heparin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Peptides and Heparin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Peptides and Heparin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Peptides and Heparin Revenue and Market Share by Regions (2015-2020)
7.2 China Peptides and Heparin Sales and Growth Rate (2015-2020)
7.3 Japan Peptides and Heparin Sales and Growth Rate (2015-2020)
7.4 Korea Peptides and Heparin Sales and Growth Rate (2015-2020)
7.5 India Peptides and Heparin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Peptides and Heparin Sales and Growth Rate (2015-2020)
7.7 Australia Peptides and Heparin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Peptides and Heparin Sales, Revenue and Market Share by Country
8.1.1 South America Peptides and Heparin Sales and Market Share by Country (2015-2020)
8.1.2 South America Peptides and Heparin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Peptides and Heparin Sales and Growth Rate (2015-2020)
8.3 Argentina Peptides and Heparin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Peptides and Heparin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Peptides and Heparin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Peptides and Heparin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Peptides and Heparin Sales and Growth Rate (2015-2020)
9.3 Turkey Peptides and Heparin Sales and Growth Rate (2015-2020)
9.4 Egypt Peptides and Heparin Sales and Growth Rate (2015-2020)
9.5 South Africa Peptides and Heparin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Peptides and Heparin Sales and Market Share by Type (2015-2020)
10.2 Global Peptides and Heparin Revenue and Market Share by Type (2015-2020)
10.3 Global Peptides and Heparin Price by Type (2015-2020)
11 Global Peptides and Heparin Market Segment by Application
11.1 Global Peptides and Heparin Sales Market Share by Application (2015-2020)
11.2 Global Peptides and Heparin Revenue Market Share by Application (2015-2020)
11.3 Global Peptides and Heparin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Peptides and Heparin Sales, Revenue and Growth Rate (2021-2025)
12.2 Peptides and Heparin Market Forecast by Regions (2021-2025)
12.2.1 North America Peptides and Heparin Market Forecast (2021-2025)
12.2.2 Europe Peptides and Heparin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Peptides and Heparin Market Forecast (2021-2025)
12.2.4 South America Peptides and Heparin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Peptides and Heparin Market Forecast (2021-2025)
12.3 Peptides and Heparin Market Forecast by Type (2021-2025)
12.3.1 Global Peptides and Heparin Sales Forecast by Type (2021-2025)
12.3.2 Global Peptides and Heparin Market Share Forecast by Type (2021-2025)
12.4 Peptides and Heparin Market Forecast by Application (2021-2025)
12.4.1 Global Peptides and Heparin Sales Forecast by Application (2021-2025)
12.4.2 Global Peptides and Heparin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Peptides and Heparin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Peptides and Heparin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Peptides and Heparin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Cipla Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. Cipla Ltd. Peptides and Heparin Major Business
Table 9. Cipla Ltd. Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 10. Cipla Ltd. SWOT Analysis
Table 11. Cipla Ltd. Peptides and Heparin Product and Services
Table 12. Cipla Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. VHB Life Sciences Limited Basic Information, Manufacturing Base and Competitors
Table 14. VHB Life Sciences Limited Peptides and Heparin Major Business
Table 15. VHB Life Sciences Limited Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 16. VHB Life Sciences Limited SWOT Analysis
Table 17. VHB Life Sciences Limited Peptides and Heparin Product and Services
Table 18. VHB Life Sciences Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Troikaa Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. Troikaa Pharmaceuticals Ltd. Peptides and Heparin Major Business
Table 21. Troikaa Pharmaceuticals Ltd. Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 22. Troikaa Pharmaceuticals Ltd. SWOT Analysis
Table 23. Troikaa Pharmaceuticals Ltd. Peptides and Heparin Product and Services
Table 24. Troikaa Pharmaceuticals Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Emcure Pharmaceuticals Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 26. Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Major Business
Table 27. Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 28. Emcure Pharmaceuticals Pvt. Ltd. SWOT Analysis
Table 29. Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Product and Services
Table 30. Emcure Pharmaceuticals Pvt. Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Samarth Life Sciences Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Major Business
Table 33. Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 34. Samarth Life Sciences Pvt. Ltd. SWOT Analysis
Table 35. Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Product and Services
Table 36. Samarth Life Sciences Pvt. Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Gland Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 38. Gland Pharma Limited Peptides and Heparin Major Business
Table 39. Gland Pharma Limited Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 40. Gland Pharma Limited SWOT Analysis
Table 41. Gland Pharma Limited Peptides and Heparin Product and Services
Table 42. Gland Pharma Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. United Biotech (P) Limited Basic Information, Manufacturing Base and Competitors
Table 44. United Biotech (P) Limited Peptides and Heparin Major Business
Table 45. United Biotech (P) Limited Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 46. United Biotech (P) Limited SWOT Analysis
Table 47. United Biotech (P) Limited Peptides and Heparin Product and Services
Table 48. United Biotech (P) Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 50. Bharat Biotech Peptides and Heparin Major Business
Table 51. Bharat Biotech Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 52. Bharat Biotech SWOT Analysis
Table 53. Bharat Biotech Peptides and Heparin Product and Services
Table 54. Bharat Biotech Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Biological E Limited Basic Information, Manufacturing Base and Competitors
Table 56. Biological E Limited Peptides and Heparin Major Business
Table 57. Biological E Limited Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 58. Biological E Limited SWOT Analysis
Table 59. Biological E Limited Peptides and Heparin Product and Services
Table 60. Biological E Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Celon Laboratories Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 62. Celon Laboratories Pvt. Ltd. Peptides and Heparin Major Business
Table 63. Celon Laboratories Pvt. Ltd. Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 64. Celon Laboratories Pvt. Ltd. SWOT Analysis
Table 65. Celon Laboratories Pvt. Ltd. Peptides and Heparin Product and Services
Table 66. Celon Laboratories Pvt. Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Biocon Limited Basic Information, Manufacturing Base and Competitors
Table 68. Biocon Limited Peptides and Heparin Major Business
Table 69. Biocon Limited Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 70. Biocon Limited SWOT Analysis
Table 71. Biocon Limited Peptides and Heparin Product and Services
Table 72. Biocon Limited Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Sun Pharmaceutical Industries Ltd. Peptides and Heparin Major Business
Table 75. Sun Pharmaceutical Industries Ltd. Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 76. Sun Pharmaceutical Industries Ltd. SWOT Analysis
Table 77. Sun Pharmaceutical Industries Ltd. Peptides and Heparin Product and Services
Table 78. Sun Pharmaceutical Industries Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Wockhardt Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Wockhardt Ltd. Peptides and Heparin Major Business
Table 81. Wockhardt Ltd. Peptides and Heparin Total Revenue (USD Million) (2017-2018)
Table 82. Wockhardt Ltd. SWOT Analysis
Table 83. Wockhardt Ltd. Peptides and Heparin Product and Services
Table 84. Wockhardt Ltd. Peptides and Heparin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Peptides and Heparin Sales by Manufacturer (2018-2019) (K MT)
Table 86. Global Peptides and Heparin Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Peptides and Heparin Sales by Regions (2015-2020) (K MT)
Table 88. Global Peptides and Heparin Sales Market Share by Regions (2015-2020)
Table 89. Global Peptides and Heparin Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Peptides and Heparin Sales by Countries (2015-2020) (K MT)
Table 91. North America Peptides and Heparin Sales Market Share by Countries (2015-2020)
Table 92. North America Peptides and Heparin Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Peptides and Heparin Revenue Market Share by Countries (2015-2020)
Table 94. Europe Peptides and Heparin Sales by Countries (2015-2020) (K MT)
Table 95. Europe Peptides and Heparin Sales Market Share by Countries (2015-2020)
Table 96. Europe Peptides and Heparin Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Peptides and Heparin Sales by Regions (2015-2020) (K MT)
Table 98. Asia-Pacific Peptides and Heparin Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Peptides and Heparin Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Peptides and Heparin Sales by Countries (2015-2020) (K MT)
Table 101. South America Peptides and Heparin Sales Market Share by Countries (2015-2020)
Table 102. South America Peptides and Heparin Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Peptides and Heparin Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Peptides and Heparin Sales by Countries (2015-2020) (K MT)
Table 105. Middle East & Africa Peptides and Heparin Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Peptides and Heparin Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Peptides and Heparin Revenue Market Share by Countries (2015-2020)
Table 108. Global Peptides and Heparin Sales by Type (2015-2020) (K MT)
Table 109. Global Peptides and Heparin Sales Share by Type (2015-2020)
Table 110. Global Peptides and Heparin Revenue by Type (2015-2020) (USD Million)
Table 111. Global Peptides and Heparin Revenue Share by Type (2015-2020)
Table 112. Global Peptides and Heparin Sales by Application (2015-2020) (K MT)
Table 113. Global Peptides and Heparin Sales Share by Application (2015-2020)
Table 114. Global Peptides and Heparin Sales Forecast by Regions (2021-2025) (K MT)
Table 115. Global Peptides and Heparin Market Share Forecast by Regions (2021-2025)
Table 116. Global Peptides and Heparin Sales Forecast by Type (2021-2025) (K MT)
Table 117. Global Peptides and Heparin Market Share Forecast by Type (2021-2025)
Table 118. Global Peptides and Heparin Sales Forecast by Application (2021-2025)
Table 119. Global Peptides and Heparin Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Peptides and Heparin Picture
Figure 2. Global Sales Market Share of Peptides and Heparin by Type in 2019
Figure 3. Insulin Picture
Figure 4. Teriparatide Picture
Figure 5. Liraglutide Picture
Figure 6. Leuprolide Picture
Figure 7. Leuprolide Picture
Figure 8. Exenatide Picture
Figure 9. Calcitonin Picture
Figure 10. Enaxaparin Sodium Picture
Figure 11. Heparin Sodium Picture
Figure 12. Peptides and Heparin Sales Market Share by Application in 2018
Figure 13. Diabetes Picture
Figure 14. Infectious Diseases Picture
Figure 15. Cancer Picture
Figure 16. Osteoporosis Picture
Figure 17. Global Peptides and Heparin Market Status and Outlook (2015-2025) (USD Million)
Figure 18. United States Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Canada Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Mexico Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Germany Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. France Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. UK Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Russia Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Italy Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 26. China Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Japan Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Korea Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. India Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Southeast Asia Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Australia Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 32. Brazil Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Egypt Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Saudi Arabia Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 35. South Africa Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Turkey Peptides and Heparin Revenue (Value) and Growth Rate (2015-2025)
Figure 37. Global Peptides and Heparin Sales Market Share by Manufacturer in 2019
Figure 38. Global Peptides and Heparin Revenue Market Share by Manufacturer in 2019
Figure 39. Top 3 Peptides and Heparin Manufacturer (Revenue) Market Share in 2019
Figure 40. Top 6 Peptides and Heparin Manufacturer (Revenue) Market Share in 2019
Figure 41. Key Manufacturer Market Share Trend
Figure 42. Global Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 43. Global Peptides and Heparin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. Global Peptides and Heparin Revenue Market Share by Regions (2015-2020)
Figure 45. Global Peptides and Heparin Revenue Market Share by Regions in 2018
Figure 46. North America Peptides and Heparin Sales and Growth Rate (2015-2020)
Figure 47. Europe Peptides and Heparin Sales and Growth Rate (2015-2020)
Figure 48. Asia-Pacific Peptides and Heparin Sales and Growth Rate (2015-2020)
Figure 49. South America Peptides and Heparin Sales and Growth Rate (2015-2020)
Figure 50. Middle East & Africa Peptides and Heparin Sales and Growth Rate (2015-2020)
Figure 51. North America Peptides and Heparin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. North America Peptides and Heparin Sales Market Share by Countries (2015-2020)
Figure 53. North America Peptides and Heparin Sales Market Share by Countries in 2018
Figure 54. North America Peptides and Heparin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 55. North America Peptides and Heparin Revenue Market Share by Countries in 2018
Figure 56. United States Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Canada Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Mexico Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Europe Peptides and Heparin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Europe Peptides and Heparin Revenue Market Share by Countries (2015-2020)
Figure 61. Europe Peptides and Heparin Revenue Market Share by Countries in 2019
Figure 62. Germany Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 63. UK Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 64. France Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Russia Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Italy Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Asia-Pacific Peptides and Heparin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. Asia-Pacific Peptides and Heparin Sales Market Share by Regions 2019
Figure 69. Asia-Pacific Peptides and Heparin Revenue Market Share by Regions 2019
Figure 70. China Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Japan Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Korea Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 73. India Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Southeast Asia Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 75. South America Peptides and Heparin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. South America Peptides and Heparin Sales Market Share by Countries in 2019
Figure 77. South America Peptides and Heparin Revenue Market Share by Countries in 2019
Figure 78. Brazil Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Argentina Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Middle East and Africa Peptides and Heparin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 81. Middle East and Africa Peptides and Heparin Sales Market Share by Countries in 2019
Figure 82. Middle East and Africa Peptides and Heparin Revenue Market Share by Countries (2015-2020)
Figure 83. Middle East and Africa Peptides and Heparin Revenue Market Share by Countries in 2019
Figure 84. Saudi Arabia Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 85. Egypt Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 86. Turkey Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 87. South Africa Peptides and Heparin Sales and Growth Rate (2015-2020) (K MT)
Figure 88. Global Peptides and Heparin Sales and Growth Rate (2021-2025) (K MT)
Figure 89. Global Peptides and Heparin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 90. North America Sales Peptides and Heparin Market Forecast (2021-2025) (K MT)
Figure 91. Europe Sales Peptides and Heparin Market Forecast (2021-2025) (K MT)
Figure 92. Asia-Pacific Sales Peptides and Heparin Market Forecast (2021-2025) (K MT)
Figure 93. South America Sales Peptides and Heparin Market Forecast (2021-2025) (K MT)
Figure 94. Middle East & Africa Sales Peptides and Heparin Market Forecast (2021-2025) (K MT)
Figure 95. Sales Channel: Direct Channel vs Indirect Channel
未分画ヘパリンの世界市場（～2026年） Market Analysis and Insights: Global Unfractionated Heparin Market The global Unfractionated Heparin market size is projected to reach US$ 978.8 million by 2026, from US$ 941.8 million in 2020, at a CAGR of 3.6%% during 2021-2026. Global Unfractionated Heparin Scope and Market Size Unfractionated He…- ヘパリンカルシウムの世界市場（～2026年） Market Analysis and Insights: Global Calcium Heparin Market The global Calcium Heparin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Calcium Heparin Scope and Market Size Calcium Heparin market is segmented by Type, …
- ペプチドの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Peptides market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Peptides market report provides a de…
- 超低分子量ヘパリン（ULMWH）の世界市場（～2026年） Market Analysis and Insights: Global Ultra-low Molecular Weight Heparin (ULMWH) Market The global Ultra-low Molecular Weight Heparin (ULMWH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ultra-low Molecular Weight He…
- ペプチドの世界市場（～2026年） Market Analysis and Insights: Global Peptides Market The global Peptides market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Peptides Scope and Market Size Peptides market is segmented by Type, and by Application. Players,…